INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

20,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
Thomas H. Kean, Jr.RSelf
CBChubb Ltd
Partial sale
SELL$15K – $50KMar 26, 2026Apr 13, 2026
traded Mar 26, 2026
+18dHouse PTR

Evidence

Page 329 of 524
← PrevNext →
23
CM
Chang MichelleChief Financial Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL
$65K
800 sh
Apr 10, 2026
Apr 13, 2026
traded Apr 10, 2026
+3d
SEC Form 4

Evidence

23
CM
Chang MichelleChief Financial Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$124K
1,500 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

23
CM
Chang MichelleChief Financial Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$87K
1,033 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

22
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$23K
6,596 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.66M
1.00M sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.71M
1.00M sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

21
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KMar 26, 2026Apr 13, 2026
traded Mar 26, 2026
+18dHouse PTR

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.91M
1.00M sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

20
Thomas H. Kean, Jr.RSelf
WATWATERS CORP /DE/
Partial sale
SELL$1,001 – $15KMar 10, 2026Apr 13, 2026
traded Mar 10, 2026
+34dHouse PTR

Evidence

19
EM
Erlinger Joseph M.President, McDonald's USA
MCDMCDONALDS CORP
Open-market sale · 10b5-1 plan
SELL$806K
2,626 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

19
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$4.16M
201.9K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

19
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$1.61M
14.7K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

17
CJ
Cornelissen Bart JanSR. VICE PRESIDENT & CFO
XNCRXencor Inc
Open-market sale
SELL$43K
3,499 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$234K
17.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$627K
5,700 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$204K
15.7K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

16
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
40.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

16
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
900 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,193 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$307K
2,699 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$515K
4,606 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$464K
4,100 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$238K
18.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

16
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$810K
7,295 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$129K
1,100 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$30K
2,100 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
500 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$5,392
400 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

13
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$47K
3,338 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

13
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
700 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$116K
1,000 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

12
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
82.3K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

12
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$295K
13.8K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

11
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$24K
500 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

11
PC
Perducat CyrilSVP, Chief Technology Officer
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$78K
198 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

11
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Open-market sale · 10b5-1 plan
SELL$892K
200.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

10
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
10.0K sh
Apr 8, 2026Apr 13, 2026
traded Apr 8, 2026
+5dSEC Form 4

Evidence

8
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
60.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

8
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$80K
1,703 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence